LAMB2 and melanoma: The results obtained from medaka and HER-mrk models suggest that Xmrk can regulate laminin and integrin-based mechanisms in human melanoma, but there may be mechanistic differences, e.g., in MAPK and MMP signaling that require additional characterization.